Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Merck
Express Scripts
Mallinckrodt
Moodys

Last Updated: May 19, 2022

CLINICAL TRIALS PROFILE FOR RENVELA


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Renvela

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00785629 ↗ A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD Completed DaVita Dialysis N/A 2009-02-01 The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629 ↗ A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD Completed Fresenius Medical Care North America N/A 2009-02-01 The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629 ↗ A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD Completed Genzyme, a Sanofi Company N/A 2009-02-01 The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629 ↗ A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD Completed Novartis Pharmaceuticals N/A 2009-02-01 The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629 ↗ A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD Completed Shire N/A 2009-02-01 The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629 ↗ A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD Completed Denver Nephrologists, P.C. N/A 2009-02-01 The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Renvela

Condition Name

Condition Name for Renvela
Intervention Trials
Hyperphosphatemia 9
Chronic Kidney Disease 6
Insulin Sensitivity 2
Kidney Failure 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Renvela
Intervention Trials
Kidney Diseases 15
Renal Insufficiency, Chronic 13
Hyperphosphatemia 10
Kidney Failure, Chronic 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Renvela

Trials by Country

Trials by Country for Renvela
Location Trials
United States 85
China 14
Puerto Rico 3
Denmark 2
Italy 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Renvela
Location Trials
New York 8
Texas 6
California 6
Colorado 5
Massachusetts 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Renvela

Clinical Trial Phase

Clinical Trial Phase for Renvela
Clinical Trial Phase Trials
Phase 4 2
Phase 3 8
Phase 2 7
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Renvela
Clinical Trial Phase Trials
Completed 23
Recruiting 2
Terminated 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Renvela

Sponsor Name

Sponsor Name for Renvela
Sponsor Trials
Genzyme, a Sanofi Company 7
Shire 3
The University of Texas Health Science Center at San Antonio 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Renvela
Sponsor Trials
Industry 26
Other 20
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Moodys
Merck
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.